To establish a predictive model for BC recurrence with comprehensive integration of relevant clinical factors, we collected 25 clinically relevant features that are clinically common and readily available from patients with BC from electronic medical records, including CA125 expression, coagulation function (Fbg, FVIII and D-dimer), tumor diameter, molecular subtype, and previous strategy of therapy, among others. Here, MUC16 is linked to breast cancer.